FrancophonIA/ELRC3.0 huggingface dataset:
English: Peak plasma concentration occurs at 1.5-2 hours after oral administration for irbesartan and 1-2.5 hours for hydrochlorothiazide.
Estonian: Ravimi maksimaalne kontsentratsioon plasmas saavutatakse irbesartaani puhul 1,5...2 tundi ja hüdroklorotiasiidi puhul 1...2,5 tundi pärast suukaudset manustamist.
English: Hydrochlorothiazide is one of a group of medicines (called thiazide diuretics) that causes increased urine output and so causes a lowering of blood pressure.
Estonian: Hüdroklorotiasiid kuulub ravimite gruppi (tiasiiddiureetikumid), mis põhjustavad vee väljaviimist organismist ja alandavad sellega vererõhku.
English: However, occasionally dizziness or weariness may occur during treatment of high blood pressure.
Estonian: Vererõhu ravi ajal võib siiski mõnikord tekkida pööritustunne ja väsimus.
English: Each tablet contains 26.65 mg of lactose (as lactose monohydrate).
Estonian: Üks tablett sisaldab 26,65 mg laktoosi (laktoosmonohüdraadina).
English: abnormal urination
Estonian: urineerimishäired
English: Lithium: reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Estonian: Liitiumi ja angiotensiini konverteeriva ensüümi inhibiitorite kooskasutamisel on teatatud liitiumi seerumikontsentratsiooni ja toksilisuse pöörduvast suurenemisest.
English: Uncommon side effects (may affect up to 1 in 100 people): diarrhoea low blood pressure fainting heart rate increased flushing swelling sexual dysfunction (problems with sexual performance) blood tests may show lowered levels of potassium and sodium in your blood.
Estonian: Aeg-ajalt esinevad kõrvaltoimed (võib esineda kuni 1 inimesel 100-st): kõhulahtisus, madal vererõhk, nõrkus, kiire südamerütm, naha punetus, tursed, seksuaaldüsfunktsioon (suguelu häired), vereproov võib näidata naatriumi ja kaaliumi taseme vähenemist.
English: You must tell your doctor if you think you are (or might become) pregnant.
Estonian: Rääkige arstile, kui arvate end olevat rase (või planeerite rasestumist).
English: No dosage adjustment is necessary in patients with renal impairment whose creatinine clearance is ≥ 30 ml/min.
Estonian: Annust ei ole vaja kohandada neerutalitluse häirega patsientidel kreatiniini kliirensiga ≥ 30 ml/min.
English: Unit dose blister packs of 56 x 1 tablet for delivery in hospitals are also available.
Estonian: Haiglate jaoks on saadaval ka üheannuselised perforeeritud blisterpakendid 56 tabletiga.
English: Co-administration of thiazide diuretics may increase the incidence of hypersensitivity reactions to allopurinol;
Estonian: Koosmanustamine tiasiiddiureetikumidega võib suurendada ülitundlikkusreaktsioonide esinemissagedust allopurinoolile.
English: No dosage adjustment of CoAprovel is necessary in patients with mild to moderate hepatic impairment (see section 4.3).
Estonian: Kerge kuni mõõduka raskusega maksakahjustusega patsientidel ei ole vaja CoAprovel'i annust kohandada (vt lõik 4.3).
English: Two large randomised, controlled trials (ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and VA NEPHRON-D (The Veterans Affairs Nephropathy in Diabetes)) have examined the use of the combination of an ACE-inhibitor with an angiotensin II receptor blocker.
Estonian: Reniin-angiotensiin-aldosteroon-süsteemi (RAAS) kahekordne blokaad Kahes suures juhuslikustatud, kontrollitud uuringus ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) ja VA NEPHRON-D (The Veterans Affairs
English: depression, sleep disturbances
Estonian: depressioon, unehäired
English: An increased risk of non-melanoma skin cancer (NMSC) [basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)] with increasing cumulative dose of hydrochlorothiazide (HCTZ) exposure has been observed in two epidemiological studies based on the Danish National Cancer Registry.
Estonian: Taani Riikliku Vähiregistri põhjal on kahes epidemioloogilises uuringus täheldatud mitte-melanoomse nahavähi (basaalrakk-kartsinoomi ja lamerakk-kartsinoomi) riski tõusu seoses hüdroklorotiasiidi kumulatiivse süsteemse saadavuse suurenemisega.
English: Based on available data from epidemiological studies, cumulative dosedependent association between HCTZ and NMSC has been observed.
Estonian: Epidemioloogiliste uuringute andmete põhjal on täheldatud kumulatiivsest annusest sõltuvat seost hüdroklorotiasiidi ja mitte-melanoomse nahavähi vahel.
English: The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, red and yellow ferric oxides (E172).
Estonian:  Teised koostisosad on mikrokristalne tselluloos, naatriumkroskarmelloos, laktoosmonohüdraat, magneesiumstearaat, kolloidne ränidioksiid, preželatiniseeritud maisitärklis, punane ja kollane raudoksiid (E172).
English: Your doctor will normally advise you to stop taking CoAprovel before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of CoAprovel.
Estonian: Arst soovitab üldjuhul lõpetada CoAprovel'i võtmise enne kui rasestute või niipea kui olete jäänud rasedaks ja määrab tavaliselt CoAprovel'i asemel mõne teise ravimi, sest CoAprovel'i ei soovitata kasutada raseduse varajases järgus ning seda ei tohi kasutada pärast 3 raseduskuud, sest võib põhjustada tõsist kahju sündivale lapsele kasutamisel pärast kolmandat raseduskuud.
English: The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, red and yellow ferric oxides, carnauba wax.
Estonian: Teised koostisosad on laktoosmonohüdraat, mikrokristalne tselluloos, naatriumkroskarmelloos, hüpromelloos, ränidioksiid, magneesiumstearaat, titaandioksiid, makrogool 3000, punane ja kollane raudoksiid, karnaubavaha.
English: Alcohol: potentiation of orthostatic hypotension may occur;
Estonian: Ortostaatiline hüpotensioon võib tugevneda.
English: Should exposure to AIIRAs have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended.
Estonian: Kui AIIRA on kasutatud raseduse teisel trimestril või hiljem on soovitatav sonograafiliselt kontrollida loote neerutalitlust ja koljut.
English: Fertility and reproductive performance were not affected in studies of male and female rats even at oral doses of irbesartan causing some parental toxicity (from 50 to 650 mg/kg/day), including mortality at the highest dose.
Estonian: Isegi irbesartaani toksilisust tekitavad suukaudsed annused (50-650 mg/kg/ööpäevas) ei mõjutanud uuringutes isaste ja emaste rottide fertiilsust ning sigimisjõudlust, sealhulgas suremust suurima annuse korral.
English: CoAprovel 150 mg/12.5 mg may be administered in patients whose blood pressure is not adequately controlled with hydrochlorothiazide or irbesartan 150 mg alone; CoAprovel 300 mg/12.5 mg may be administered in patients insufficiently controlled by irbesartan 300 mg or by CoAprovel 150 mg/12.5 mg.
Estonian: Kliinilisel sobivusel kaalutakse üleminekut monoteraapialt kindlaksmääratud annustes fikseeritud kombinatsioonidele:  CoAprovel 150 mg/12,5 mg võib manustada patsientidele, kelle vererõhk ei ole adekvaatselt kontrollitud hüdroklorotiasiidi või 150 mg irbesartaaniga eraldi võetuna;  CoAprovel 300 mg/12,5 mg võib manustada patsientidele, kelle vererõhu kontrollimiseks
English: vertigo, paraesthesia, light-headedness, restlessness
Estonian: vertiigo, paresteesia, kerge pööritustunne, rahutus
English: Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or to other sulfonamide-derived substances (hydrochlorothiazide is a sulfonamide-derived substance) Second and third trimesters of pregnancy (see sections 4.4 and 4.6) Severe renal impairment (creatinine clearance < 30 ml/min) Refractory hypokalaemia, hypercalcaemia
Estonian: Ülitundlikkus toimeainete või lõigus 6.1 loetletud mis tahes abiaine või teiste sulfoonamiidide derivaatide suhtes (hüdroklorotiasiid on sulfoonamiidi derivaat).
English: cardiac arrhythmias
Estonian: südame arütmiad
English: No teratogenic effects were seen in rats given irbesartan and hydrochlorothiazide in combination at doses that produced maternal toxicity.
Estonian: Teratogeenset toimet ei täheldatud, kui emastele rottidel manustati kombineeritult irbesartaani ja hüdroklorotiasiidi toksilises annuses.
English: The use of HCTZ may also need to be reconsidered in patients who have experienced previous NMSC (see also section 4.8).
Estonian: Mitte-melanoomset nahavähki eelnevalt põdenud patsientidel peab uuesti kaaluma hüdroklorotiasiidi kasutamise asjakohasust (vt ka lõik 4.8).
English: jaundice hepatitis, abnormal liver function
Estonian: ikterus hepatiit, muutused maksafunktsiooni näitajates
English: Each film-coated tablet contains 89.5 mg of lactose (as lactose monohydrate).
Estonian: Üks õhukese polümeerikattega tablett sisaldab 89,5 mg laktoosi (laktoosmonohüdraadina).
English: Each tablet contains 65.8 mg of lactose (as lactose monohydrate).
Estonian: Üks tablett sisaldab 65,8 mg laktoosi (laktoosmonohüdraadina).
English: Musculoskeletal and connective tissue disorders:
Estonian: Lihaste, luustiku ja sidekoe kahjustused:
English: Steadystate plasma concentrations are attained within 3 days after initiation of a once-daily dosing regimen.
Estonian: Manustamisel üks kord ööpäevas saabub püsikontsentratsioon plasmas 3 päeva pärast ravi alustamist.
English: Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate
Estonian: Tableti sisu: laktoosmonohüdraat mikrokristalne tselluloos naatriumkroskarmelloos hüpromelloos ränidioksiid magneesiumstearaat
English: There is no evidence that irbesartan would reduce or prevent diuretic-induced hyponatraemia.
Estonian: Irbesartaani hüponatreemiat vähendava või ennetava toime kohta andmed puuduvad.
English: weakness, muscle spasm
Estonian: nõrkus, lihasspasmid
English: Cartons of 56 x 1 tablets in PVC/PVDC/Aluminium perforated unit dose blisters.
Estonian: Pakendis on 56 x 1 tabletti PVC/PVDC/Alumiinium üheannuselises perforeeritud blisterpakendis.
English: Thu
Estonian: MUU
English: When measured by ambulatory blood pressure monitoring, the trough to peak effects of CoAprovel 150 mg/12.5 mg were 100%.
Estonian: Ambulatoorsel vererõhumonitooringul oli CoAprovel'i 150 mg/12,5 mg minimaalse ja maksimaalse vererõhulanguse suhe 100%.
English: Each film-coated tablet contains 53.3 mg of lactose (as lactose monohydrate).
Estonian: Üks õhukese polümeerikattega tablett sisaldab 53,3 mg laktoosi (laktoosmonohüdraadina).
English: Once daily dosing with 150 mg irbesartan and 12.5 mg hydrochlorothiazide gave systolic/diastolic mean placebo-adjusted blood pressure reductions at trough (24 hours post-dosing) of 12.9/6.9 mm Hg in patients with mild-to-moderate hypertension.
Estonian: Kerge ja mõõduka hüpertensiooniga patsientidele üks kord päevas annustatuna annab 150 mg irbesartaani ja 12,5 mg hüdroklorotiasiidi keskmise süstoolse/diastoolse platseebo-korrigeeritud vererõhu languse kuni 12,9/6,9 mmHg (24 tundi pärast annustamist).
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 300 mg/25 mg film-coated tablets.
Estonian: RAVIMPREPARAADI NIMETUS CoAprovel 300 mg/25 mg õhukese polümeerikattega tabletid.
English: There is no clinical experience with CoAprovel in patients with hepatic impairment.
Estonian: CoAprovel'i kasutamise kohta maksakahjustusega patsientidel kliinilised kogemused puuduvad.
English: decreases in serum potassium and sodium
Estonian: seerumi kaaliumi- ja naatriumisisalduse langus
English: diarrhoea
Estonian: kõhulahtisus
English: You may need to have blood checks if you take: potassium supplements salt substitutes containing potassium potassium sparing medicines or other diuretics (water tablets) some laxatives medicines for the treatment of gout therapeutic vitamin D supplements medicines to control heart rhythm medicines for diabetes (oral agents or insulins) carbamazepine (a medicine for the treatment of epilepsy).
Estonian: kaaliumi säästvaid ravimeid või teisi diureetikume (vee väljaajamistabletid), mõningaid kõhulahtisteid, podagra ravimeid, ravitoimega D-vitamiini preparaate, südamerütmi kontrollivaid ravimeid, suhkruhaiguse ravimeid (suukaudseid preparaate või insuliine), karbamasepiin (epilepsia raviks kasutatav ravim).
English: Treatment with hydrochlorothiazide, particularly long term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer).
Estonian: aliskireen; kui teil on olnud nahavähk või kui teil tekib ravi ajal ootamatu nahamuutus; ravi hüdroklorotiasiidiga, eriti pikaajaline ravi suurte annustega, võib suurendada teatud liiki nahaja huulevähi riski (mitte-melanoomne nahavähk); ravi ajal CoApprovel'iga kaitske oma nahka kokkupuute eest päikese ja UV-kiirgusega.
English: Microcrystalline cellulose Croscarmellose sodium Lactose monohydrate Magnesium stearate Colloidal hydrated silica Pregelatinised maize starch Red and yellow ferric oxides (E172)
Estonian: Mikrokristalne tselluloos naatriumkroskarmelloos laktoosmonohüdraat magneesiumstearaat kolloidne ränidioksiid preželatiniseeritud maisitärklis punane ja kollane raudoksiid (E172)
English: Irbesartan is not removed by haemodialysis.
Estonian: Irbesartaan ei ole hemodialüüsiga organismist eemaldatav.
English: No significant pharmacokinetic or pharmacodynamic interactions were observed when irbesartan was coadministered with warfarin, a medicinal product metabolised by CYP2C9.
Estonian: Irbesartaani manustamisel koos varfariiniga, ravimiga, mis metaboliseerub CYP2C9 kaudu ei ilmnenud märkimisväärseid farmakokineetilisi ega farmakodünaamilisi koostoimeid.
English: Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Pregelatinised starch Silicon dioxide Magnesium stearate Red and yellow ferric oxides
Estonian: Tableti sisu: laktoosmonohüdraat mikrokristalne tselluloos naatriumkroskarmelloos preželatiniseeritud maisitärklis ränidioksiid magneesiumstearaat punane ja kollane raudoksiid
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 150 mg/12.5 mg tablets.
Estonian: RAVIMPREPARAADI NIMETUS CoAprovel 150 mg/12,5 mg tabletid.
English: Each film-coated tablet of CoAprovel 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
Estonian: Iga CoAprovel 300 mg/ 25 mg õhukese polümeerikattega tablett sisaldab 300 mg irbesartaani ja 25 mg hüdroklorotiasiidi.
English: Irbesartan exhibits linear and dose proportional pharmacokinetics over the dose range of 10 to 600 mg. A less than proportional increase in oral absorption at doses beyond 600 mg was observed; the mechanism for this is unknown.
Estonian: Üle 600 mg (2-kordne maksimaalne soovitatud annus) suukaudse annuse manustamisel oli imendumise suurenemine proportsionaalsest väiksem, selle nähtuse mehhanism ei ole selge.
English: Antidiabetic medicinal products (oral agents and insulins): dosage adjustment of the antidiabetic medicinal product may be required (see section 4.4);
Estonian: Võib osutuda vajalikuks antidiabeetilise ravimi annuse korrigeerimine (vt lõik 4.4).
English: The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3350, red, yellow and black ferric oxides, pregelatinised starch, carnauba wax.
Estonian: Teised koostisosad on laktoosmonohüdraat, mikrokristalne tselluloos, naatriumkroskarmelloos, hüpromelloos, ränidioksiid, magneesiumstearaat, titaandioksiid, makrogool 3350, punane,
English: Pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Estonian: Roosa, kaksikkumer, ovaalne, sissepressitud südame kujutis ühel poolel ja sissegraveeritud number 2788 teisel poolel.
English: Olmesartan 40 Irbesartan 300 Candesartan 32
Estonian: Irbesartaan 300
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 300 mg/12.5 mg tablets.
Estonian: RAVIMPREPARAADI NIMETUS CoAprovel 300 mg/12,5 mg tabletid.
English: Other interactions: the hyperglycaemic effect of beta-blockers and diazoxide may be enhanced by thiazides.
Estonian: Tiasiidid võivad tugevdada beetablokaatorite ja diasoksiidi hüperglükeemilist toimet.
English: Cartons of 14 tablets in PVC/PVDC/Aluminium blisters.
Estonian: Pakendis on 14 tabletti PVC/PVDC/Alumiinium blistris.
English: Hypromellose Titanium dioxide Macrogol 3350
Estonian: Õhuke polümeerikate: laktoosmonohüdraat hüpromelloos titaandioksiid makrogool 3350 punane ja must raudoksiid karnaubavaha
English: Exacerbation or activation of systemic lupus erythematosus has been reported with the use of thiazide diuretics.
Estonian: Tiasiiddiureetikumide kasutamisel on esinenud süsteemse erütematoosse luupuse ägenemist või aktiveerumist.
English: Posology
Estonian: Kirjeldus
English: What CoAprovel looks like and contents of the pack CoAprovel 300 mg/25 mg film-coated tablets are pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Estonian: Kuidas CoAprovel välja näeb ja pakendi sisu CoAprovel 300 mg/25 mg õhukese polümeerikattega tablett on roosa, kaksikkumer, ovaalne, sissepressitud südamekujuga ühel poolel ja sissegraveeritud number 2788 teisel poolel.
English: Cartons of 28 tablets in PVC/PVDC/Aluminium blisters.
Estonian: Pakendis on 28 tabletti PVC/PVDC/Alumiinium blistris.
English: Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 25 mg
Estonian: Iga tablett sisaldab: 300 mg irbesartaani ja 25 mg hüdroklorotiasiidi.
English: Older people
Estonian: Eakad
English: EU/1/98/086/008 - 14 tablets EU/1/98/086/004 - 28 tablets EU/1/98/086/005 - 56 tablets EU/1/98/086/010 - 56 x 1 tablets EU/1/98/086/006 - 98 tablets
Estonian: EU/1/98/086/008 - 14 tabletti EU/1/98/086/004 - 28 tabletti EU/1/98/086/005 - 56 tabletti EU/1/98/086/010 - 56 x 1 tabletti EU/1/98/086/006 - 98 tabletti
English: Talk to your doctor before taking CoAprovel and if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems or have a kidney transplant if you suffer from heart problems if you suffer from liver problems o if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
Estonian: kui teil on südamehaigus, kui teil on maksahaigus, kui teil on suhkurtõbi, kui teil on erütematoosne luupus (tuntud ka kui luupus või SLE), kui teil on primaarne aldosteronism (haigus, mille puhul on suurenenud hormooni aldosteroon produktsioon, selle tulemusena esineb naatriumi peetus ning vererõhk tõuseb), kui te võtate mõnda alljärgnevat ravimit kõrge vererõhu raviks:
English: Cartons of 56 tablets in PVC/PVDC/Aluminium blisters.
Estonian: Pakendis on 56 tabletti PVC/PVDC/Alumiinium blistris.
English: CoAprovel 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Estonian: CoAprovel 300 mg/25 mg tabletid irbesartaan/hüdroklorotiasiid
English: Each tablet of CoAprovel 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Estonian: Iga CoAprovel 150 mg/ 12,5 mg tablett sisaldab 150 mg irbesartaani ja 12,5 mg hüdroklorotiasiidi.
English: Cartons of 98 tablets in PVC/PVDC/Aluminium blisters.
Estonian: Pakendis on 98 tabletti PVC/PVDC/Alumiinium blistris.
English: Renal impairment
Estonian: valu rindkeres
English: What CoAprovel looks like and contents of the pack CoAprovel 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Estonian: Kuidas CoAprovel välja näeb ja pakendi sisu CoAprovel 150 mg/12,5 mg tablett on virsikuvärvi, kaksikkumer, ovaalne, sissepressitud südamekujuga ühel poolel ja sissegraveeritud number 2775 teisel poolel.
English: EU/1/98/086/007 - 14 tablets EU/1/98/086/001 - 28 tablets EU/1/98/086/002 - 56 tablets EU/1/98/086/009 - 56 x 1 tablets EU/1/98/086/003 - 98 tablets
Estonian: EU/1/98/086/007 - 14 tabletti EU/1/98/086/001 - 28 tabletti EU/1/98/086/002 - 56 tabletti EU/1/98/086/009 - 56 x 1 tabletti EU/1/98/086/003 - 98 tabletti
English: dyspepsia, dysgeusia
Estonian: düspepsia, düsgeusia
English: dizziness
Estonian: Eritumine
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Üks õhukese polümeerikattega tablett sisaldab 300 mg irbesartaani ja 25 mg hüdroklorotiasiidi.
English: CoAprovel 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Estonian: CoAprovel 150 mg/12,5 mg tabletid on pakendatud 14, 28, 56 või 98 tableti kaupa blisterpakendisse.
English: orthostatic dizziness
Estonian: ortostaatiline pööritustunne
English: Special Populations
Estonian: jäsemete turse
English: Antigout medicinal products: dosage adjustments of antigout medicinal products may be necessary as hydrochlorothiazide may raise the level of serum uric acid.
Estonian: Hüdroklorotiasiidi kusihappe seerumisisaldust tõstva toime tõttu võib vajalikuks osutuda podagravastaste ravimite annuse korrigeerimine.
English: CoAprovel 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Estonian: CoAprovel'i 300 mg/25 mg õhukese polümeerikattega tabletid on pakendatud 14, 28, 30, 56, 84, 90 või 98 tableti kaupa blisterpakendisse.
English: Tablet core:
Estonian: Seedetrakti häired:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Üks tablett sisaldab 150 mg irbesartaani ja 12,5 mg hüdroklorotiasiidi.
English: CoAprovel 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Estonian: CoAprovel'i 150 mg/12,5 mg õhukese polümeerikattega tabletid on pakendatud 14, 28, 30, 56, 84, 90 või 98 tableti kaupa blisterpakendisse.
English: What CoAprovel looks like and contents of the pack CoAprovel 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
Estonian: Kuidas CoAprovel välja näeb ja pakendi sisu CoAprovel 300 mg/12,5 mg tablett on virsikuvärvi, kaksikkumer, ovaalne, sissepressitud südamekujuga ühel poolel ja sissegraveeritud number 2776 teisel poolel.
English: Each tablet of CoAprovel 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Estonian: Iga CoAprovel 300 mg/ 12,5 mg tablett sisaldab 300 mg irbesartaani ja 12,5 mg hüdroklorotiasiidi.
English: EU/1/98/086/023 - 14 tablets EU/1/98/086/024 - 28 tablets EU/1/98/086/031 - 30 tablets EU/1/98/086/025 - 56 tablets EU/1/98/086/028 - 56 x 1 tablets EU/1/98/086/026 - 84 tablets EU/1/98/086/034 - 90 tablets EU/1/98/086/027 - 98 tablets
Estonian: EU/1/98/086/023 - 14 tabletti EU/1/98/086/024 - 28 tabletti EU/1/98/086/031 - 30 tabletti EU/1/98/086/025 - 56 tabletti EU/1/98/086/028 - 56 x 1 tabletti EU/1/98/086/026 - 84 tabletti EU/1/98/086/034 - 90 tabletti EU/1/98/086/027 - 98 tabletti
English: CoAprovel 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Estonian: CoAprovel 300 mg/12,5 mg tabletid on pakendatud 14, 28, 56 või 98 tableti kaupa blisterpakendisse.
English: EU/1/98/086/011 - 14 tablets EU/1/98/086/012 - 28 tablets EU/1/98/086/029 - 30 tablets EU/1/98/086/013 - 56 tablets EU/1/98/086/014 - 56 x 1 tablets EU/1/98/086/021 - 84 tablets EU/1/98/086/032 - 90 tablets EU/1/98/086/015 - 98 tablets
Estonian: EU/1/98/086/011 - 14 tabletti EU/1/98/086/012 - 28 tabletti EU/1/98/086/029 - 30 tabletti EU/1/98/086/013 - 56 tabletti EU/1/98/086/014 - 56 x 1 tabletti EU/1/98/086/021 - 84 tabletti EU/1/98/086/032 - 90 tabletti EU/1/98/086/015 - 98 tabletti